PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Biol Psychiatry. Author manuscript; available in PMC Sep 15, 2012.
Published in final edited form as:
PMCID: PMC3142297
NIHMSID: NIHMS282602
Strong Association of The Alcohol Dehydrogenase 1B Gene (ADH1B) With Alcohol Dependence And Alcohol-induced Medical Diseases
Dawei Li,1* Hongyu Zhao,2,3 and Joel Gelernter1,3,4
1 Department of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut 06511, USA
2 Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, Connecticut 06511, USA
3 Department of Genetics, School of Medicine, Yale University, New Haven, Connecticut 06511, USA
4 VA Connecticut Healthcare Center, West Haven, Connecticut, USA
* To whom correspondence should be addressed: Dawei Li, Ph.D., Department of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut 06511, USA. or 300 George Street, Suite 503, New Haven, Connecticut 06511, USA. dawei.li/at/yale.edu
Background
The alcohol dehydrogenase 1B gene (ADH1B) is hypothesized to affect predisposition to alcohol dependence (AD) and abuse. A variant of the ADH1B gene (rs1229984 or Arg48His; previously referred to as Arg (*1) and His (*2)) has been reported to be associated with reduced rates of alcohol and drug dependence. Different studies have produced inconclusive results regarding association between rs1229984 (or rs2066702) and substance dependence.
Methods
Using the cumulative association study literature from the past 21 years from both English and Chinese-language publications, this meta-analysis seeks to clarify the contradictory findings and to examine whether the aggregate data provide new evidence of significant association.
Results
The results, based on a large sample size (9,638 cases and 9,517 controls), suggested strong associations with alcohol dependence and abuse as well as alcohol-induced liver diseases, with an allelic (Arg vs. His) P value being 1×10−36 and odds ratio (OR) 2.06 (1.84, 2.31) under the random effects model. The dominant and recessive models produced larger ORs of 2.17 and 3.05, respectively. When more stringent criteria and sub-group analyses were imposed, the associations remained consistent, and were strongest in various Asian groups (allelic P = 7×10−42 and OR = 2.24 (1.99, 2.51) with ORs of 2.16 and 4.11 for dominant and recessive models, respectively).
Conclusions
Our findings provide further strong evidence for the involvement of the ADH1B gene in the pathogenesis of alcohol dependence and abuse as well as for some alcohol-induced medical diseases in the multiple ethnic populations, in particular, in certain Asian populations.
Keywords: Meta-analysis, Addiction, Ethanol Metabolism, Drinking, Liver Disease
Alcohol and drug dependence, which are multifactorial and chronic relapsing disorders, constitute major public health problems. The isoenzymes coded by the alcohol dehydrogenase 1B and 1C genes (ADH1B and ADH1C) and aldehyde dehydrogenase 2 gene (ALDH2) metabolize alcohol into acetaldehyde and acetaldehyde into acetate, respectively. The enzyme encoded by ADH1B is a member of the alcohol dehydrogenase family, which metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. Among the patients with alcohol dependence (AD), alcoholic cirrhosis occurs in around 10%, hepatitis in 10-35%(1), and alcohol-induced pancreatitis in approximately 5%(2). Alcohol dehydrogenase 1B was hypothesized to be an important ethanol-oxidizing enzyme that may alter genetic susceptibility to AD as well as alcoholic liver disease, cirrhosis, and pancreatitis (the latter two are often alcohol-induced diseases)(3).
The ADH1B gene is located on chromosome 4q21–q23. Naturally occurring single nucleotide polymorphisms (SNPs) may be capable of altering ethanol metabolism(4). One common form of a SNP (rs1229984 or Arg48His in exon 3) is ADH1B Arg (previously referred to as *1). The ADH1B His (*2) allele encodes a super-active allozyme, which has been reported to be associated with lower rates of AD in numerous association studies. ADH1B His is common among Asian populations and moderately common in Russian and Jewish populations, but rare in western and central Europeans(5). In some African and Mexican populations rs2066702 (Arg370Cys, previously designated ADH1B *3) is observed. On the other hand, some individuals with a high daily intake of alcohol develop alcohol-induced diseases, and a proposed mechanism is that the His allele (or Cys allele) can increase the level of acetaldehyde after a certain dose of ethanol, and then result in enhanced objective and subjective negative reactions to alcohol, which would in turn reduce the likelihood of habitual alcohol use, AD, and alcohol-induced liver diseases.
Several issues prompted us to carry out an updated meta-analysis to seek further evidence regarding the proposed association with ADH1B. First, the findings of case-control studies have been controversial and nonconclusive. Second, rates of AD differ across the ethnic populations, even among Asian populations. Third, the low prevalence of ADH1B His/His individuals in subjects of European ancestry makes it particularly difficult to determine the effect of homozygous His/His in that population due to the need for very large sample size. The previous meta-analyses(3, 6, 7) regarding the role of ADH1B His in alcoholism, however, involved relatively small numbers of subjects available at the time of the analyses and thus the results were limited or incomplete. Therefore, a new meta-analysis with systematic statistical approaches is required.
There have been many published genetic association studies in recent years from multiple populations. We performed a comprehensive and systematic meta-analysis with AD and alcohol abuse as well as alcohol-induced medical diseases, based on both English and Chinese-language publications, to clarify the potential association and to compare the results with those in previous studies.
Inclusion criteria
Eligible studies had to meet the following criteria: they (a) were published in peer-reviewed journals; (b) contained original and independent data; (c) presented sufficient data to calculate the odds ratio (OR) with confidence interval (CI) and P value; (d) were association studies investigating ADH1B Arg/His and (or) ADH1B Arg/Cys; (e) described or referenced appropriate genotyping methods; (f) investigated alcohol, heroin, cocaine, or methamphetamine dependence (or abuse) diagnosed by valid published criteria (tobacco and cannabis were not included due to lack of sufficient relevant publications). For the studies investigating alcoholic liver disease, cirrhosis, or chronic pancreatitis, the cases were considered as alcoholics with the induced diseases due to alcoholism. The patients with cirrhosis were diagnosed by histological, clinical, radiological, and (or) endoscopic findings; (g) had no description of other major psychiatric disorders for patients in the studies (this information was not available in all the studies); and (h) used unrelated individuals in case-control studies. Authors were contacted in cases where we determined it would be useful to have additional information regarding their studies.
Statistical analyses
Association studies were divided among those dealing with samples with Asian ancestries, those with European ancestries, those with African ancestries, and those with Mexican (or Native American) ancestries. For studies that contained data from multiple populations, each was considered effectively as an independent study. Data from the case-control studies were summarized by two-by-two tables. From each table a log-odds ratio and its sampling variance were calculated(8). The Cochran s χ2-based Q statistic test was performed in order to assess heterogeneity to ensure that each group of studies was suitable for meta-analysis. Where heterogeneity was found, the random effects model, which yields a wider CI, was adopted; otherwise, both the fixed and random effects models were adopted. A test for funnel plot asymmetry, described by Egger et al.(9), was used to assess evidence for publication bias. The test used a linear regression approach to measure funnel plot asymmetry on the natural logarithm of the OR. The larger the deviation of each study from the funnel curve, the more pronounced the asymmetry. Results from small studies will scatter widely at the bottom of the graph, with the spread narrowing among larger studies. The significance of the intercept was evaluated using the T test.
For datasets with evidence for publication bias, the “Duval and Tweedie's Trim and Fill” procedure(10) was used to impute the number of potentially-missing studies. In the absence of bias, the funnel plot would be symmetric with respect to the summary effect. If there are more small studies on the right than on the left, some studies may be missing from the left. The Trim and Fill procedure imputes these missing studies, adds them to the analysis, and then re-computes the adjusted overall effect size.
ORs were pooled using the method of DerSimonian and Laird(11), and 95% CIs were constructed using Woolf s method(12). The significance of the overall OR was determined using the Z-test. To measure sensitivity of our analysis results, each study was removed in turn from the total, and the remainder then reanalyzed. This procedure was used to ensure that no individual study was entirely responsible for the combined results. In addition, different combinations of the ethnic populations and different combinations of the alcohol-induced medical conditions (e.g., alcoholic liver disease, cirrhosis, and pancreatitis) were also analyzed. Genotypic analyses were carried out under both dominant and recessive models. Retrospective analysis was performed to better understand the potential effect of year of publication upon the results. The type I error rate was set at 0.05. The tests were two-tailed. The methods for literature search and those for linkage disequilibrium (LD) and haplotype structure analyses are shown in Supplement 1.
The combined search yielded 1024 references. After discarding the overlapping references and those which clearly did not meet the criteria, 91 studies remained. These studies were then filtered to ensure conformity with the inclusion criteria (13 studies(1326) were excluded (Supplement 1)). In the end, 78 case-control studies (Table S1 in Supplement 1) met our criteria for inclusion. These studies included 48 studies (5, 14, 2761) of Asian populations; 21 studies(43, 6278) of European populations; four studies(7982) of Mexican Americans; one(76) of African Americans; and four studies(76, 79, 83) investigating the Cys allele (Native Americans, African Americans, and Trinidadians). Among these studies, two(48, 68) investigated heroin dependence or abuse; three(76) investigated multi-drug dependence, and the other 73 studies investigated AD or AD and alcohol abuse. These 73 studies included 18 studies(28, 32, 35, 36, 44, 46, 50, 62, 63, 65, 66, 7072, 74, 75, 77) in which the alcoholic patients were affected by alcoholic liver disease, cirrhosis, and (or) pancreatitis (10 of the 18 studies also included data for the patients without any alcohol-induced diseases). These studies included 9,638 cases and 9,517 controls. The results are detailed below.
Based on all these samples, the frequency of the protective ADH1B His allele varied widely across the populations: high in the Asian normal populations 69% (19% – 91%) and affected subjects, 51% (9% – 93%); low in the European normal populations 5.5% (1% – 43%) and affecteds, 6.9% (0% – 51%); and rare in the Mexican normal populations 3% (2% – 7%) and affecteds, 4% (2% – 8%). On average, the frequencies of the His allele were 34% and 45% in the combined patients and controls, respectively. The ADH1B Cys allele was found in African Americans, native Americans, and Trinidadians with frequencies of 11% (1% – 30%) in controls and 7% (0% – 18%) in affecteds. In the 48 Asian studies, 45 studies showed lower frequency in cases than in controls; in the 21 European studies, 16 showed lower frequency in cases than in controls; in the four Mexican American studies, two showed lower frequency; and all the four studies of the Cys allele, that allele showed lower frequency in cases than in controls. Only the studies of AD and alcohol abuse were included in the following meta-analysis.
All the combined studies of AD and alcohol abuse, in particular, the Asian studies, showed strong association, with allelic (Arg vs. His) P values of 1×10−36 (OR = 2.06 (1.84, 2.31)) and 7×10−42 (OR = 2.24 (1.99, 2.51)), respectively (Table 1). The strong association was also found under both dominant (ArgArg + ArgHis vs. HisHis) and recessive (ArgArg vs. ArgHis + HisHis) models (P < 9×10−23 in all the populations and P < 2×10−31 in Asians) with much lower heterogeneity under the dominant model (P > 0.01). Strong association was also revealed in the combined Asian and European-ancestry studies (allelic P = 2×10−36), however, it was moderate in the European (P = 0.0002) and non-Asian studies (P = 2×10−5). The strict random effects model was applied when evidence for significant heterogeneity between studies was found throughout this meta-analysis.
Table 1
Table 1
Results of the overall and sub-grouped studies
In some studies the AD subjects had alcoholic liver disease, cirrhosis, or pancreatitis (designated as “induced diseases” in Table 1). Meta-analysis of these studies showed significant evidence of association (P = 4×10−12 and OR = 1.76 (1.5, 2.07)). The association was stronger in the Asian populations (P = 3×10−12 and OR = 1.97 (1.54, 2.52)) but was not significant in the European populations (Table 1). The patients with only alcoholic liver disease also produced significant association (P = 0.005). For the subjects only with cirrhosis, the significant association was found with P = 9×10−8, which was also significant in Asians (P = 4×10−8) but not in Europeans.
In order to understand whether these strong associations were due only to the alcohol-induced medical diseases, we also analyzed the samples without any of these diseases. The results showed that there was not any decrease on the level of significance compared with the results with these induced diseases (e.g., P = 9×10−33 and OR = 2.1 (1.86, 2.37), Table 1).
Two studies investigated both AD and alcohol abuse; seven studies had no explicit description of the patients as alcohol dependent (the possibility that subjects with a diagnosis of alcohol abuse could not be excluded); the other studies clearly described the patients as alcohol dependent (these “definite” alcohol dependent patients without any alcohol-induced diseases were designated as “AD” in Table 1). The meta-analysis based on these “definite” alcohol dependent subjects also showed that there was no major change on the significance level of the association. Strong association was still detected in all the combined populations, in particular, in the Asian populations and in the combined Asians and Europeans for both allelic and genotypic analyses. For instance, the allelic P values were 2×10−29 (OR = 2.12 (1.86, 2.42)) and 1×10−33 (OR = 2.28 (1.99, 2.6)) in the combined populations and the Asian populations, respectively (Table 1).
For the Cys allele, evidence of significant association was detected with P value of 7×10−5 and OR of 2.74 (1.67, 4.51) under the recessive model (ArgArg vs. ArgCys + CysCys). Statistical significance was also identified in allelic analysis (Table 1). The studies of AD and alcohol abuse combined with those from the Cys allele showed stronger association with allelic P value of 1×10−38 (OR = 2.08 (1.86, 2.32)).
The four studies with the Cys allele, two studies of heroin dependence and abuse, and three studies of multi-drug dependence were analyzed separately. However, they were also combined with AD and alcohol abuse considering that alcohol and drug dependence have been reported to share common genetic risk(84-86). The results showed that there was still strong evidence of association with ADH1B His and Cys in both allelic (Arg vs. His and Cys) and genotypic analyses (Table 1). The overall P value was 4×10−31 and OR was 1.98 (1.76, 2.22) for the allelic analysis, which was stronger under the dominant model. The Asian studies produced an allelic P value of 6×10−32 (OR = 2.17 (1.9, 2.46)), and significant results were found consistently under the dominant and recessive models (P = 9×10−32 and 2×10−31, respectively). Significant association was further detected in the combined Asian and European studies and non-Asian studies (P = 1×10−28 and 1×10−6, respectively). In contrast, the European studies showed moderate evidence of association with an allelic P value of 0.0007. The Mexican studies showed weak association (P = 0.034) possibly due to limited sample size. In addition, significant association was also revealed in the combined Mexican Americans and African Americans (including the studies investigating the Cys allele), and the P values were 0.0001 and 4×10−15 for the allelic analysis and recessive model, respectively.
The demography of the association studies are shown in Table S1 (see Supplement 1). The results of overall and sub-grouped meta-analyses are shown for both allelic and genotypic analyses in Table 1. Other sub-grouped analyses are shown in Table S2 in Supplement 1. The forest plots of the allelic and genotypic analyses are shown in Figure 1, and Figures S1 and S2 in Supplement 1.
Figure 1
Figure 1
Forest plots of ln(OR) with 95% CI for the allelic analysis. Black squares indicate the ln(OR) (ln(OR) can be better fitted than OR), with the size of the square inversely proportional to its variance, and horizontal lines represent the 95% CIs. The pooled (more ...)
Other Heterogeneity Analyses
Heterogeneity Q tests were also performed for differences in OR between the studies using the World Health Organization s International Statistical Classification ofDiseases and Related Health Problems (ICD)(87), the American Psychiatric Association s Diagnostic and Statistical Manual of Mental Disorders (DSM)(88) system, or other identified criteria and studies with no description of diagnosis criteria; between the English-language publications and Chinese-language publications; and between the studies of China-mainland and Taiwan and those of other countries or regions. The results showed that there was only evidence of marginal heterogeneity regarding diagnosis criteria using the recessive model (P(Q) = 0.04), but no heterogeneity using the allelic analysis and dominant model; and weak heterogeneity regarding publication languages using the allelic analysis (P(Q) = 0.01), but no heterogeneity under the dominant and recessive models. The weak heterogeneity between the languages may be due to the heterogeneity between the Asian studies because all the Chinese-language publications were investigating Chinese populations. The results are shown in Table S3 in Supplement 1.
Publication Bias Analyses
Publication bias is an important issue in meta-analysis. In the present study, no evidence of significant publication bias was found in the studies of AD and alcohol abuse with European samples (P(T) > 0.05) for either allelic or genotypic analysis. However, evidence of publication bias was found in those studies with Asian samples as well as when all the populations were combined as described below. For the allelic analysis, in the studies of AD and alcohol abuse with Asian samples, the Egger's regression P value (1-tailed) was 0.0002, and Kendall's tau (Begg and Mazumdar rank correlation)(89) P value (1-tailed) was 0.005; the analysis of Duval and Tweedie's trim and fill showed that there might potentially be eight missing studies, and the adjusted overall effect size was 2.50(2.21, 2.83) under the random effects model; in all the populations the Egger's regression P value was 0.0001, and Kendall's tau P value was 0.04; the trim and fill analysis showed that there might be six potential missing studies, and the adjusted effect size was 2.17(1.93, 2.43) under the random effects model. For the dominant model, in the Asian samples the P(T) was 0.032, there might be four potential missing studies, and the adjusted effect size was 2.24(1.96, 2.57). However, it should be noted that all the three adjusted values of effect size were larger than the corresponding observed values, which implied stronger associations in the adjusted studies compared with the observed studies. That is, the imputed missing studies were positive.
The classic fail-safe analysis showed that for the allelic analysis at least 8,512 assumed non-significant studies could bring the overall P(Z) value to > 0.05 for all the studies of AD and alcohol abuse (6,606 for the Asian studies and 62 for the European studies); for the dominant model at least 2,839 assumed non-significant studies could bring the P value to > 0.05 (2,466 for the Asian studies); and for the recessive model it needed at least 5,882 assumed non-significant studies (4,337 for the Asian studies and 64 for the European studies). The results further supported the strong associations detected in this meta-analysis. The funnel plots are shown for the allelic and genotypic analyses of all the studies of AD and alcohol abuse in Figures S3-S5 in Supplement 1. Figure S3 in Supplement 1 indicates the increase of effect size from the observed to adjusted values.
Sensitivity and Retrospective Analyses
The sensitivity analyses showed that no individual study among the 78 that were included biased the findings to the extent that it could account for the strong observed associations. For example, the studies of AD and alcohol abuse showed strong consistency, regardless of the data set removed, with the allelic P values always between 3×10−39 and 2×10−33 among the 70 studies; For the dominant and recessive models, the results were also strong and consistent, regardless of the data set removed, with the P values never > 3×10−31 among the 57 studies and never > 3×10−21 among the 66 studies, respectively. The results are shown for the allelic analysis, dominant model, and recessive model in Tables S4–S6 (see Supplement 1), respectively.
The asymptote lines of the analyses in retrospect based on 21 publication years showed that the cumulative synthesis tended towards stability in recent years, in line with the overall results of this meta-analysis. The results of the allelic analysis are shown in Figure 2; and the results of the genotypic analyses are shown in Figures S6 and S7 in Supplement 1. The P(Z) and P(Q) values are shown in Tables S7-S9 in Supplement 1.
Figure 2
Figure 2
Retrospective analysis for the allelic analysis. Analysis in retrospect was based on publication year since 1990.
LD and Haplotype Structure Analyses
The genes encoding alcohol dehydrogenase alpha, beta, and gamma subunits are organized as a gene cluster on chromosome 4q. Strong LD was found in the region of the gene cluster of the ADH6, ADH1A, ADH1B, ADH1C, and ADH7 genes (Figure S8 in Supplement 1), which were consistent with the studies by colleagues(76, 90). The first four genes were in a strong LD structure (large triangle in dark red and blue that was composed of multiple haplotype blocks), and ADH1A and ADH1B were in a same haplotype block, which indicated that the contribution of the gene cluster to the association effect on alcohol and drug dependence was not independent. Since ADH1B haplotypes have not been fully evaluated, it will be necessary for subsequent studies to investigate the roles of other polymorphisms in the same haplotype block (e.g., the nonsynonymous SNPs shown on the LD plot or in Table S10 in Supplement 1) or the polymorphisms on other genes within the strong LD structure. The LD plots are shown for the Asian and European populations in Figures S8 and S9 (see Supplement 1), respectively.
Strong evidence of association was found between the ADH1B Arg48His and alcohol abuse and dependence, as well as alcohol-induced medical diseases, in multiple populations, in particular, in Asians, in this meta-analysis. The His allele was highly prevalent in the Asian ethnic populations, particularly in northeast Asians. It was slightly lower in some Chinese aboriginal groups (e.g., Elunchan) but was higher in others (e.g., Atayal and Paiwan). Figure 3 and Table S11 in Supplement 1 show the His48 allele frequencies of by location.These aboriginal groups (e.g., Atayal and Bunun) may to some extent contribute to the significant heterogeneity between the Asian studies. However, the allele frequency was very low in Europeans, Native Americans, and Africans, and thus, the homozygous His/His was not observed at all in some studies of these populations. This constitutes one of the reasons that the association studies, reported by different research groups, produced discrepant or contradictory results. There are some other possible explanations: for example, the His48 allele could (because of LD) be co-inherited with other ADH variants that might affect the risk of alcoholism and which could differ between Europeans and Asians(91). Another reason may be found in the population genetics of alcohol metabolizing enzyme variants (Supplement 1).
Figure 3
Figure 3
His48 allele frequencies among different populations. Blue and red represent His48 and Arg48, respectively. Upper graphs are based on the patients and , lower graphs on controls. Only those 57 studies that described their geographic origins specifically (more ...)
Most published genome-wide association studies (GWAS) of addictions have focused on smoking behavior or AD. Four GWAS of AD with a range of 1,100 to 1,897 patients have been published thus far, and only two SNPs have received modest support of replication in a subsequent study(92). One GWAS(93) has identified nine SNPs located in genes, for example, the CDH13 and ADH1C genes, to be nominally associated with AD, including rs1614972 on the ADH1C gene (P = 0.0001). Another study (94) reported that fifteen SNPs yielded P < 10−5, but in two independent replication series, no SNP passed a replication threshold of 0.05. Edenberg et al.(95) found that 15 SNPs in the ADH gene cluster were nominally significant. However, no single SNP met genome-wide significance. Other studies(96, 97) also failed to report genome-wide significance in the ADH gene cluster. Another study(98) compared six published association studies between AD and the seven ADH genes and only a few SNPs reached the P value < 0.001 across this region.
Compared with previous meta-analyses(3, 6, 7) that applied different statistical methods(99104) from those in our studies(105109), the present study identified much stronger evidence of association for ADH1B. The differences included: the study by Zintzaras et al.(3), in which the latest dataset was published in 2004, included 33 studies (no more than one third of our sample size); only included English publications; provided OR without specific P values; and found no association between liver disease and ADH1B His. The meta-analysis by Luczak et al.(6), in which the latest dataset was also published in 2004, only included Asian samples; of there, there were 685 cases and 890 controls from 12 studies (less than 9% of our sample size); performed genotypic analysis without allelic analysis and specific P values; and no association was found for the analysis of His/His vs. Arg/His by this meta-analysis. The older study by Whitfield et al.(7) published in 2002, included 22 studies (17 publications) between ADH1B His and alcoholism. In contrast, our meta-analysis included the largest sample size up to the present (9,638 cases and 9,517 controls) from both 72 English and six Chinese-language publications (it was important to include Chinese-language publications as well); used both strict and extended criteria to measure the effect estimates; performed both allelic and genotypic analyses under the strict random effects model; applied systematic analysis procedure, as shown in the results, to study additional questions not answered in those previous meta-analyses; and found consistently stronger evidence of associations for ADH1B His with both AD and alcohol-induced diseases (our results have the same direction as a recent study(110) showing that Arg48/Arg48 can increase the risk of esophageal cancer among drinkers). Our results also provided significant evidence of association of this polymorphism (also Cys) with drug dependence although those studies were excluded from meta-analyses of AD. In addition, the procedure of extended-quality score suggested in our previous study(8) was also applied to assist the assessment of quality of the individual association studies.
To conclude, using the cumulative data from 78 English and Chinese publications, this meta-analysis found strong associations of ADH1B Arg48His in the combined populations, in particular, in Asians, using both the allelic and genotypic analyses. When both strict and extended criteria as well as the sub-group analyses were imposed, the strong associations remained consistent. Our findings support that the His allele can greatly lower the risk against AD and alcohol abuse as well as alcohol-induced medical diseases, and thus, provide strong evidence for the involvement of the human ADH1B gene in the pathogenesis of AD and alcohol-induced diseases in multiple populations, in particular, in the Asian populations.
Supplementary Material
01
Acknowledgments
This work was supported by the research grants DA12849, DA12690, AA017535, AA12870, and AA11330 from the National Institutes of Health, USA.
Footnotes
Conflict of Interest
The authors reported no biomedical financial interests or potential conflicts of interest.
Electronic-database information
Accession Numbers and URLs for data in this article are as follows:
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ for genomic structure of ADH1B;
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim for ADH1B;
Genotype data, http://www.hapmap.org/ for ADH1B;
Genome data, http://genome.ucsc.edu/ for ADH1B.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
1. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis. 1988;8:12–25. [PubMed]
2. Dreiling DA, Koller M. The natural history of alcoholic pancreatitis: update 1985. Mt Sinai J Med. 1985;52:340–342. [PubMed]
3. Zintzaras E, Stefanidis I, Santos M, Vidal F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology. 2006;43:352–361. [PubMed]
4. Yoshida A, Hsu LC, Yasunami M. Genetics of human alcohol-metabolizing enzymes. Prog Nucleic Acid Res Mol Biol. 1991;40:255–287. [PubMed]
5. Osier M, Pakstis AJ, Kidd JR, Lee JF, Yin SJ, Ko HC, et al. Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism. Am J Hum Genet. 1999;64:1147–1157. [PubMed]
6. Luczak SE, Glatt SJ, Wall TL. Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians. Psychol Bull. 2006;132:607–621. [PubMed]
7. Whitfield JB. Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet. 2002;71:1247–1250. author reply 1250–1241. [PubMed]
8. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 2006;15:1995–2002. [PubMed]
9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629–634. [PMC free article] [PubMed]
10. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463. [PubMed]
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188. [PubMed]
12. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–253. [PubMed]
13. Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry. 1995;152:1219–1221. [PubMed]
14. Higuchi S, Muramatsu T, Matsushita S, Murayama M, Hayashida M. Polymorphisms of ethanol-oxidizing enzymes in alcoholics with inactive ALDH2. Hum Genet. 1996;97:431–434. [PubMed]
15. Wei F, Fan J, Shen Y, Tian C, Zhou R, Zheng X, et al. A control study on the polymorphism of the ADH and ALDH genes in high risk alcoholic families of Han ethnic population. Chin J Psychiatry. 1999;32:164–166.
16. Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PA, Richter MM, et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet. 2009;18:580–593. [PMC free article] [PubMed]
17. Khan AJ, Husain Q, Choudhuri G, Parmar D. Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis. Drug Alcohol Depend. 2010;109:190–197. [PubMed]
18. Tsuchihashi-Makaya M, Serizawa M, Yanai K, Katsuya T, Takeuchi F, Fujioka A, et al. Gene-environmental interaction regarding alcohol-metabolizing enzymes in the Japanese general population. Hypertens Res. 2009;32:207–213. [PubMed]
19. Shimosegawa T, Kume K, Masamune A. SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan. J Gastroenterol Hepatol. 2008;23(Suppl 1):S82–86. [PubMed]
20. Kuo PH, Kalsi G, Prescott CA, Hodgkinson CA, Goldman D, van den Oord EJ, et al. Association of ADH and ALDH genes with alcohol dependence in the Irish Affected Sib Pair Study of alcohol dependence (IASPSAD) sample. Alcohol Clin Exp Res. 2008;32:785–795. [PMC free article] [PubMed]
21. Choi IG, Kee BS, Son HG, Ham BJ, Yang BH, Kim SH, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur Neuropsychopharmacol. 2006;16:123–128. [PubMed]
22. Sherman DI, Ward RJ, Warren-Perry M, Williams R, Peters TJ. Association of restriction fragment length polymorphism in alcohol dehydrogenase 2 gene with alcohol induced liver damage. BMJ. 1993;307:1388–1390. [PMC free article] [PubMed]
23. Segado Soriano A, Santiago Dorrego C, Banares Canizares R, Alvarez Fernandez E, Bandres Moya F, Gomez-Gallego F. [Genetic susceptibility to the development of acute alcoholic hepatitis: role of genetic mutations in dehydrogenase alcohol, aldehyde dehydrogenase and cytochrome P450 2E1] Rev Clin Esp. 2005;205:528–532. [PubMed]
24. Hendershot CS, Collins SE, George WH, Wall TL, McCarthy DM, Liang T, et al. Associations of ALDH2 and ADH1B genotypes with alcohol-related phenotypes in Asian young adults. Alcohol Clin Exp Res. 2009;33:839–847. [PMC free article] [PubMed]
25. Vaswani M, Prasad P, Kapur S. Association of ADH1B and ALDH2 gene polymorphisms with alcohol dependence: a pilot study from India. Hum Genomics. 2009;3:213–220. [PMC free article] [PubMed]
26. Shafe S, Gilder DA, Montane-Jaime LK, Joseph R, Moore S, Crooks H, et al. [Co-morbidity of Alcohol Dependence and Select Affective and Anxiety Disorders among Individuals of East Indian and African Ancestry in Trinidad and Tobago] West Indian Med J. 2009;58:164–172. [PMC free article] [PubMed]
27. Thomasson HR, Edenberg HJ, Crabb DW, Mai XL, Jerome RE, Li TK, et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet. 1991;48:677–681. [PubMed]
28. Chao YC, Liou SR, Chung YY, Tang HS, Hsu CT, Li TK, et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology. 1994;19:360–366. [PubMed]
29. Thomasson HR, Crabb DW, Edenberg HJ, Li TK, Hwu HG, Chen CC, et al. Low frequency of the ADH2*2 allele among Atayal natives of Taiwan with alcohol use disorders. Alcohol Clin Exp Res. 1994;18:640–643. [PubMed]
30. Maezawa Y, Yamauchi M, Toda G, Suzuki H, Sakurai S. Alcohol-metabolizing enzyme polymorphisms and alcoholism in Japan. Alcohol Clin Exp Res. 1995;19:951–954. [PubMed]
31. Muramatsu T, Wang ZC, Fang YR, Hu KB, Yan H, Yamada K, et al. Alcohol and aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in Shanghai. Hum Genet. 1995;96:151–154. [PubMed]
32. Yamauchi M, Maezawa Y, Toda G, Suzuki H, Sakurai S. Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. J Hepatol. 1995;23:519–523. [PubMed]
33. Chen WJ, Loh EW, Hsu YP, Chen CC, Yu JM, Cheng AT. Alcohol-metabolising genes and alcoholism among Taiwanese Han men: independent effect of ADH2, ADH3 and ALDH2. Br J Psychiatry. 1996;168:762–767. [PubMed]
34. Nakamura K, Iwahashi K, Matsuo Y, Miyatake R, Ichikawa Y, Suwaki H. Characteristics of Japanese alcoholics with the atypical aldehyde dehydrogenase 2*2. I. A comparison of the genotypes of ALDH2, ADH2, ADH3, and cytochrome P-4502E1 between alcoholics and nonalcoholics. Alcohol Clin Exp Res. 1996;20:52–55. [PubMed]
35. Tanaka F, Shiratori Y, Yokosuka O, Imazeki F, Tsukada Y, Omata M. High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease. Hepatology. 1996;23:234–239. [PubMed]
36. Chao YC, Young TH, Tang HS, Hsu CT. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Hepatology. 1997;25:112–117. [PubMed]
37. Chen WJ, Loh EW, Hsu YP, Cheng AT. Alcohol dehydrogenase and aldehyde dehydrogenase genotypes and alcoholism among Taiwanese aborigines. Biol Psychiatry. 1997;41:703–709. [PubMed]
38. Shen YC, Fan JH, Edenberg HJ, Li TK, Cui YH, Wang YF, et al. Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin Exp Res. 1997;21:1272–1277. [PubMed]
39. Shen Y, Fan J, Cui Y, Zhou R, Wang Y, Tian C, et al. A study of the correlation between alcohol dependence and polymorphism of alcohol-dehydrogenase genes and aldehyde-dehydrogenase genes among Mongolian and Han ethnic groups in China. Chin J Psychiatry. 1997;30:3–6.
40. Fan J, Shen Y, Cui Y, Tian C, Zhou R, Zhou C, et al. ADH and ALDH genes among Korea and Elunchun ethnic groups in China. Chin J Psychiatry. 1998;31:209–212.
41. Chen CC, Lu RB, Chen YC, Wang MF, Chang YC, Li TK, et al. Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet. 1999;65:795–807. [PubMed]
42. Lee JF, Lu RB, Ko HC, Chang FM, Yin SJ, Pakstis AJ, et al. No association between DRD2 locus and alcoholism after controlling the ADH and ALDH genotypes in Chinese Han population. Alcohol Clin Exp Res. 1999;23:592–599. [PubMed]
43. Amadeo S, Noble EP, Fourcade-Amadeo ML, Tetaria C, Brugiroux MF, Nicolas L, et al. Association of D2 dopamine receptor and alcohol dehydrogenase 2 genes with Polynesian alcoholics. Eur Psychiatry. 2000;15:97–102. [PubMed]
44. Chao YC, Wang LS, Hsieh TY, Chu CW, Chang FY, Chu HC. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis. Am J Gastroenterol. 2000;95:2958–2964. [PubMed]
45. Paik YK, Choi Y, Lee CG, Kim IK. Differences in Genetic Variation of ADH2 and ALDH2 between Alcoholics and Healthy Persons in Korea. Korean J Genetics. 2000;22:117–126.
46. Lee HC, Lee HS, Jung SH, Yi SY, Jung HK, Yoon JH, et al. Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci. 2001;16:745–750. [PMC free article] [PubMed]
47. Park KS, Mok JW, Chung TH. Genetic aspects and relative risk factors in alcoholism among Koreans. Korean J Genetics. 2001;23:143–150.
48. Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D. Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet. 2002;110:45–50. [PubMed]
49. Yu C, Li Y, Chen W, Yue M. Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people. Chin Med J (Engl) 2002;115:1085–1087. [PubMed]
50. Chao YC, Wang SJ, Chu HC, Chang WK, Hsieh TY. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol. 2003;38:431–436. [PubMed]
51. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res. 2004;28:374–384. [PubMed]
52. Kim SA, Kim JW, Song JY, Park S, Lee HJ, Chung JH. Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients. Alcohol. 2004;34:115–120. [PubMed]
53. Chai YG, Oh DY, Chung EK, Kim GS, Kim L, Lee YS, et al. Alcohol and aldehyde dehydrogenase polymorphisms in men with type I and Type II alcoholism. Am J Psychiatry. 2005;162:1003–1005. [PubMed]
54. Choi IG, Son HG, Yang BH, Kim SH, Lee JS, Chai YG, et al. Scanning of genetic effects of alcohol metabolism gene (ADH1B and ADH1C) polymorphisms on the risk of alcoholism. Hum Mutat. 2005;26:224–234. [PubMed]
55. Kim DJ, Park BL, Yoon S, Lee HK, Joe KH, Cheon YH, et al. 5' UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism. Biochem Biophys Res Commun. 2007;357:1135–1141. [PubMed]
56. Kim DJ, Choi IG, Park BL, Lee BC, Ham BJ, Yoon S, et al. Major genetic components underlying alcoholism in Korean population. Hum Mol Genet. 2008;17:854–858. [PubMed]
57. Maruyama K, Harada S, Yokoyama A, Naruse S, Hirota M, Nishimori I, et al. Association analysis among polymorphisms of the various genes and chronic alcoholic pancreatitis. J Gastroenterol Hepatol. 2008;23(Suppl 1):S69–72. [PubMed]
58. He G, Zhong S, Gao L, Bao J, Gao C, Wu W, et al. [Research on the Relationship Between ADH2,CYP2E1 Gene Polymorphism and Alcohol Dependence Syndrome] J Med Res. 2009;38:67–70.
59. Jing Q, Zhong S, Gao L, Wang X, Dou S, He G, et al. [Association analyses of ADH2,ALDH2 AND CYP4502E1 genetic polymorphisms with alcohol dependence syndrome in Yunnan Han population] Chin J Drug Depend. 2009;18:341–370.
60. Guo W, Wang Q, Lanzi G, Luobu O, Ma X, Wang Y, et al. Interaction among genes influencing ethanol metabolism and sex is association with alcohol use disorders in a Tibet population. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:561–569. [PubMed]
61. Tan EC, Lim L, Leong JY, Lim JY, Lee A, Yang J, et al. Alcohol and aldehyde dehydrogenase polymorphisms in Chinese and Indian populations. Subst Use Misuse. 2010;45:1–14. [PubMed]
62. Couzigou P, Fleury B, Groppi A, Cassaigne A, Begueret J, Iron A. Genotyping study of alcohol dehydrogenase class I polymorphism in French patients with alcoholic cirrhosis. The French Group for Research on Alcohol and Liver. Alcohol Alcohol. 1990;25:623–626. [PubMed]
63. Day CP, Bashir R, James OF, Bassendine MF, Crabb DW, Thomasson HR, et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology. 1991;14:798–801. [PubMed]
64. Gilder FJ, Hodgkinson S, Murray RM. ADH and ALDH genotype profiles in Caucasians with alcohol-related problems and controls. Addiction. 1993;88:383–388. [PubMed]
65. Vidal F, Perez J, Panisello J, Toda R, Gutierrez C, Richart C. Atypical liver alcohol dehydrogenase in the Spanish population: its relation with the development of alcoholic liver disease. Alcohol Clin Exp Res. 1993;17:782–785. [PubMed]
66. Pares X, Farres J, Pares A, Soler X, Panes J, Ferre JL, et al. Genetic polymorphism of liver alcohol dehydrogenase in Spanish subjects: significance of alcohol consumption and liver disease. Alcohol Alcohol. 1994;29:701–705. [PubMed]
67. Espinos C, Sanchez F, Ramirez C, Juan F, Najera C. Polymorphism of alcohol dehydrogenase genes in alcoholic and nonalcoholic individuals from Valencia (Spain) Hereditas. 1997;126:247–253. [PubMed]
68. Neumark YD, Friedlander Y, Thomasson HR, Li TK. Association of the ADH2*2 allele with reduced ethanol consumption in Jewish men in Israel: a pilot study. J Stud Alcohol. 1998;59:133–139. [PubMed]
69. Whitfield JB, Nightingale BN, Bucholz KK, Madden PA, Heath AC, Martin NG. ADH genotypes and alcohol use and dependence in Europeans. Alcohol Clin Exp Res. 1998;22:1463–1469. [PubMed]
70. Rodrigo L, Alvarez V, Rodriguez M, Perez R, Alvarez R, Coto E. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study. Scand J Gastroenterol. 1999;34:303–307. [PubMed]
71. Borras E, Coutelle C, Rosell A, Fernandez-Muixi F, Broch M, Crosas B, et al. Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology. 2000;31:984–989. [PubMed]
72. Ogurtsov PP, Garmash IV, Miandina GI, Guschin AE, Itkes AV, Moiseev VS. Alcohol dehydrogenase ADH2-1 and ADH2-2 allelic isoforms in the Russian population correlate with type of alcoholic disease. Addict Biol. 2001;6:377–383. [PubMed]
73. Chambers GK, Marshall SJ, Robinson GM, Maguire S, Newton-Howes J, Chong NL. The genetics of alcoholism in Polynesians: alcohol and aldehyde dehydrogenase genotypes in young men. Alcohol Clin Exp Res. 2002;26:949–955. [PubMed]
74. Frenzer A, Butler WJ, Norton ID, Wilson JS, Apte MV, Pirola RC, et al. Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol. 2002;17:177–182. [PubMed]
75. Vidal F, Lorenzo A, Auguet T, Olona M, Broch M, Gutierrez C, et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. J Hepatol. 2004;41:744–750. [PubMed]
76. Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J. Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Hum Mol Genet. 2007;16:380–390. [PMC free article] [PubMed]
77. Cichoz-Lach H, Celinski K, Slomka M. Alcohol-metabolizing enzyme gene polymorphisms and alcohol chronic pancreatitis among Polish individuals. HPB (Oxford) 2008;10:138–143. [PubMed]
78. Sherva R, Rice JP, Neuman RJ, Rochberg N, Saccone NL, Bierut LJ. Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans. Alcohol Clin Exp Res. 2009;33:848–857. [PMC free article] [PubMed]
79. Wall TL, Carr LG, Ehlers CL. Protective association of genetic variation in alcohol dehydrogenase with alcohol dependence in Native American Mission Indians. Am J Psychiatry. 2003;160:41–46. [PubMed]
80. Konishi T, Calvillo M, Leng AS, Feng J, Lee T, Lee H, et al. The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Exp Mol Pathol. 2003;74:183–189. [PubMed]
81. Konishi T, Luo HR, Calvillo M, Mayo MS, Lin KM, Wan YJ. ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles. Alcohol Clin Exp Res. 2004;28:1145–1152. [PubMed]
82. Montano Loza AJ, Ramirez Iglesias MT, Perez Diaz I, Cruz Castellanos S, Garcia Andrade C, Medina Mora ME, et al. Association of alcohol-metabolizing genes with alcoholism in a Mexican Indian (Otomi) population. Alcohol. 2006;39:73–79. [PubMed]
83. Ehlers CL, Montane-Jaime K, Moore S, Shafe S, Joseph R, Carr LG. Association of the ADHIB*3 allele with alcohol-related phenotypes in Trinidad. Alcohol Clin Exp Res. 2007;31:216–220. [PubMed]
84. Fu Q, Heath AC, Bucholz KK, Nelson E, Goldberg J, Lyons MJ, et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry. 2002;59:1125–1132. [PubMed]
85. Xian H, Scherrer JF, Grant JD, Eisen SA, True WR, Jacob T, et al. Genetic and environmental contributions to nicotine, alcohol and cannabis dependence in male twins. Addiction. 2008;103:1391–1398. [PubMed]
86. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry. 1999;56:655–661. [PubMed]
87. World Health Organization. World Health Organization s International Statistical Classification of Diseases and Related Health Problems (ICD) Geneva: WHO;
88. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM) Washington, DC: American Psychiatric Press;
89. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. [PubMed]
90. Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am J Hum Genet. 2006;78:973–987. [PubMed]
91. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30:5–13. [PubMed]
92. Treutlein J, Rietschel M. Genome-Wide Association Studies of Alcohol Dependence and Substance Use Disorders. Curr Psychiatry Rep 2011 [PubMed]
93. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, et al. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry. 2009;66:773–784. [PubMed]
94. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, et al. A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A. 2010;107:5082–5087. [PubMed]
95. Edenberg HJ, Koller DL, Xuei X, Wetherill L, McClintick JN, Almasy L, et al. Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res. 34:840–852. [PMC free article] [PubMed]
96. Lind PA, Macgregor S, Vink JM, Pergadia ML, Hansell NK, de Moor MH, et al. A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin Res Hum Genet. 2010;13:10–29. [PMC free article] [PubMed]
97. Drgon T, Zhang PW, Johnson C, Walther D, Hess J, Nino M, et al. Genome wide association for addiction: replicated results and comparisons of two analytic approaches. PLoS One. 2010;5:e8832. [PMC free article] [PubMed]
98. Birley AJ, James MR, Dickson PA, Montgomery GW, Heath AC, Martin NG, et al. ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. Hum Mol Genet. 2009;18:1533–1542. [PMC free article] [PubMed]
99. Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol. 9:Article21. [PubMed]
100. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. Meta-analysis methods. Adv Genet. 2008;60:311–334. [PubMed]
101. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–645. [PubMed]
102. Zintzaras E, Papathanasiou AA, Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet Med. 2009;11:695–706. [PubMed]
103. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med. 2008;168:1077–1089. [PubMed]
104. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol. 2005;34:1319–1328. [PubMed]
105. Li D, He L. Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res. 2007;96:112–118. [PubMed]
106. Li D, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med. 2007;9:4–8. [PubMed]
107. Li D, He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics. 2007;175:917–922. [PubMed]
108. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry. 2007;12:47–54. [PubMed]
109. Li D, He L. Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:174–178. [PubMed]
110. Yang SJ, Yokoyama A, Yokoyama T, Huang YC, Wu SY, Shao Y, et al. Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis. World J Gastroenterol. 2010;16:4210–4220. [PMC free article] [PubMed]
111. Miyazaki H, Yamaguchi Y, Takehara T. Dental arch and palate in Taiwan aboriginals--Ami, Bunun, Paiwan and Rukai tribes. Arch Oral Biol. 1993;38:729–735. [PubMed]